So-Young International (SY) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
17 Mar, 2026Executive summary
Q1 2025 revenues were RMB 297.3 million (US$41.0 million), with a net loss of RMB 33.1 million (US$4.6 million), mainly due to increased investment in expanding branded aesthetic centers.
The company is executing a vertical integration strategy, expanding its branded SoYoung Clinic network in major Chinese cities, focusing on high-quality, standardized, non-surgical treatments.
23 clinics operated in nine cities by quarter-end; 18 achieved positive monthly operating cash flow, and 16 were profitable in March.
Customer satisfaction remains high at 4.98/5, with strong growth in paid visits and treatments year-over-year.
Branded aesthetic centers achieved triple-digit year-over-year revenue growth, reflecting strong operational momentum.
Financial highlights
Total revenues down 60.6% year-over-year, mainly due to fewer medical service providers subscribing to platform services.
Aesthetic treatment services revenue surged 551.4% year-over-year to RMB 98.8 million, driven by branded center expansion.
Cost of revenues rose 29.1% year-over-year to RMB 151.4 million, mainly from branded center expansion; cost of aesthetic treatment services up 547.6%.
Operating expenses fell 20.4% year-over-year to RMB 189.3 million; sales and marketing, G&A, and R&D expenses all declined.
Gross profit for Q1 2025 was RMB 145.9 million, down from RMB 201.0 million in Q1 2024.
Net loss widened to RMB 33.1 million from RMB 21.2 million a year ago; non-GAAP net loss was RMB 31.5 million versus a profit last year.
Cash and equivalents totaled RMB 1.1 billion as of March 31, 2025, down from RMB 1.25 billion at year-end 2024.
Outlook and guidance
Q2 2025 aesthetic treatment services revenue expected between RMB 120–140 million, up 337.3%–410.1% year-over-year.
Continued investment in branded clinic network and vertical integration, prioritizing long-term value over short-term gains.
Guidance reflects current market and operating conditions and is subject to change.
Latest events from So-Young International
- Q4 revenue surged 25% YoY as branded centers drove growth and net loss narrowed sharply.SY
Q4 202525 Mar 2026 - Goodwill impairment drove a net loss, but aesthetic center revenue grew over 700% year-over-year.SY
Q4 202417 Mar 2026 - Aesthetic treatment services revenue soared 426% YoY, now the largest segment, with 50 centers targeted by year-end.SY
Q2 202517 Mar 2026 - Q2 revenue exceeded guidance, profit improved, but Q3 revenue is expected to decline.SY
Q2 202423 Jan 2026 - Q3 revenue exceeded guidance, with strong clinic and medical product growth and higher profitability.SY
Q3 202413 Jan 2026 - Aesthetic treatment revenues jumped 305% YoY, but higher costs led to a net loss.SY
Q3 202517 Nov 2025